Selected announcements of A-shares| Shanxi Huayang New Material (600281.SH), Hebei Jinniu Chemical Industry (600722.SH), and other stocks that have hit the limit up may indicate trading risks.

Focus on Today 1. Shanxi Huayang New Material: There is a risk of irrational speculation with 5 consecutive days of trading limit hikes. Once again clarified that it does not have the concept of rare earth permanent magnetism. Shanxi Huayang New Material (600281.SH) issued an announcement on abnormal stock trading fluctuations and risk warnings. The company's stock price has shown significant fluctuations recently, with accumulated gains significantly deviating from the industry average. The company's current operating scale is relatively small, with limited asset volume and a relatively low market value, which objectively makes related operations more convenient. Recently, the company's stock price has shown a significant upward trend, indicating a risk of irrational speculation. In the stock trading risk warning announcement disclosed on June 14th, the company stated that its main business and existing product system have not involved rare earth permanent magnetic fields. Today, it is clarified again that it does not have the concept of rare earth permanent magnetism. The company's main business is the recycling and processing of precious metals such as platinum, rhodium, and palladium. Recently, influenced by market conditions, the prices of precious metals have continued to rise, putting pressure on the company's raw material procurement costs accordingly. 2. C*Core Technology: Successful internal testing of a new product resistant to quantum cryptographic cards. Samples have been sent to multiple customers. C*Core Technology (688262.SH) announced that the new product CCUPHPQ01 resistant to quantum cryptographic cards developed by the company achieved success in internal testing. The anti-quantum cryptographic card CCUPHPQ01 developed by the company is a high-performance cryptographic security product designed based on the combination of anti-quantum cryptographic algorithms and classical national encryption algorithms, with the main control chip being the CCP1080T secure chip independently designed and developed by the company, supplemented by a domestic FPGA chip. Currently, the company has sent samples to multiple customers, and several customers have begun developing information security products based on the new product CCUPHPQ01 resistant to quantum cryptographic cards. 3. Lakala Payment: The H-share listing this time may face significant uncertainties in the review, filing, and approval process and final implementation. Lakala Payment (300773.SZ) issued an abnormal announcement, stating that after self-inspection, there is no violation of fair information disclosure. The company is discussing the specific progress of this H-share listing with relevant intermediaries. After the specific plan is determined, the H-share listing this time still needs to be submitted for review by the company's board of directors and shareholders' meeting, approved by the People's Bank of China, filed by the China Securities Regulatory Commission, and reviewed by regulatory authorities such as the Hong Kong Stock Exchange. There are significant uncertainties in whether this H-share listing can pass the review, filing, and approval process and be finally implemented. Investors are advised to pay attention to investment risks. 4. HeBei Jinniu Chemical Industry: There has been no significant change in the recent sales price of methanol for the company. HeBei Jinniu Chemical Industry (600722.SH) announced that the company's stock has had a cumulative deviation of more than 20% in the closing price for three consecutive trading days, indicating abnormal stock trading fluctuations. The company's main business is the production and sales of methanol, with a capacity of 200,000 tons per year. According to the self-inspection, there have been no significant changes in the company's main business. Currently, production and operation activities are normal. Based on publicly available information, the company has not found any significant adjustments in industry policies. The company believes that the methanol market currently has a high production rate, with sufficient supply in the market, and there have been no significant changes in downstream methanol demand. Recently, there has been no significant change in the company's methanol sales price. 5. Hengbao Co., Ltd.: The controlling shareholder has reduced its holdings during the period of abnormal stock price fluctuations. Hengbao Co., Ltd. (002104.SZ) disclosed an abnormal trading announcement, stating that there have been no major changes in the company's operating situation and internal and external operating environment recently. After verification, the company, controlling shareholder, and actual controller have no major undisclosed matters about the company or major matters in the planning stage. During the abnormal stock price fluctuations, the controlling shareholder of the company, Qian Jing, and the actual controller have reduced their holdings of the company's stock, consistent with the previously disclosed reduction plan, and there is no violation of the reduction. 6. Shenzhen Forms Syntron Information: There is no violation of fair information disclosure. Shenzhen Forms Syntron Information (300468.SZ) announced that the company's stock trading price has accumulated a deviation of over 30% in the closing price for three consecutive trading days from June 13th to June 17th, indicating abnormal stock trading fluctuations. After self-inspection, there is no violation of fair information disclosure. It has been verified that there is no need for corrections or supplements to the previously disclosed information. There have been no major changes in the company's operating situation and internal and external operating environments recently, and there are no major undisclosed matters or matters in the planning stage that the company should disclose. During the period of abnormal stock price fluctuations, the controlling shareholder and actual controller of the company have not engaged in buying or selling the company's stock. 7. REMEGEN: Tabasusept receives orphan drug qualification from the European Union. REMEGEN (688331.SH) announced that its product Tabasusept (trade name: Taisai) has received orphan drug qualification from the European Commission for the treatment of myasthenia gravis. This drug is the world's first innovative drug that targets the BLyS/APRIL dual-target fusion protein for the treatment of myasthenia gravis, reducing the production of pathogenic autoantibodies by blocking the BLyS and APRIL signaling pathways. The orphan drug qualification granted by the European Union will provide policy support for the development of Tabasusept in the EU, including scientific advice on research plans, partial cost reduction, application fee discounts, and market exclusivity after approval. 8. Damon Technology Group: Strategic cooperation intention with Zhiyuan Xinchuang to explore innovative applications of Siasun Robot&Automation in logistics scenarios. Damon Technology Group (688360.SH) announced that the company reached a strategic cooperation intention with Shanghai Zhiyuan Xinchuang Technology Co., Ltd. on June 17, 2025, and signed a "Strategic Cooperation Agreement." Based on each party's core advantages, the two sides will jointly explore innovative applications of Siasun Robot&Automation in the logistics scenario, including the construction and operation of the humanoid intelligent Siasun Robot&Automation data acquisition center, commercial applications, data trading models, core component research and development, and joint sales in multiple areas. The agreement is a framework agreement and does not involve specific transaction amounts. It is expected that it will not have a significant impact on the company's operating performance in the current year, and the impact on future operating performance will depend on the specific cooperation agreements signed and implemented. 9. Asia Cuanon Technology: Due to triggering the forced liquidation process, Runhetongcai plans to passively reduce its holding of 3% of the company's shares. Asia Cuanon Technology (603378.SH) announced that due to the credit account of Runhetongcai Asset Management Co., Ltd., a concerted action entity with the controlling shareholder Shanghai Chuangnengming Investment Co., Ltd., maintaining a collateral ratio lower than the liquidation line and failing to increase the collateral to raise the maintenance ratio above the supplementary protection line, the forced liquidation process has been triggered. The shares possibly affected by this forced liquidation include the company's 12.8579 million shares held by Runhetongcai, accounting for 3% of the company's total share capital. The reduction plan is planned to be carried out within three months after the disclosure of the reduction plan, and the reduction price will be determined based on the market price at the time of implementation. This matter will not lead to changes in the company's controlling shareholder and actual controller. 10. Siteway: The shareholding ratio of the National Integrated Circuit Industry Investment Fund Phase II has dropped to 6.99%. Siteway (688213.SH) announced that as of June 17, 2025, the National Integrated Circuit Industry Investment Fund Phase II, a shareholder holding more than 5% of the company's shares, has collectively reduced its holdings by 1.45 million shares through centralized bidding transactions, reducing its proportion of the company's total share capital from 7.35% to 6.99%. Business Performance 1. Beijing Jingyi Automation Equipment: The revenue for the first half of the year is expected to increase by 36.54% to 42.48% year-on-year. Beijing Jingyi Automation Equipment announced the main operating data for the first half of the year. Preliminary accounting for the first half of 2025 is expected to achieve operating income of 690 million to 720 million yuan, an increase of 36.54% to 42.48% year-on-year. Buybacks & Increase/Decrease Holdings 1. Jiangsu Nhwa Pharmaceutical: Chairman increases holdings of 237,900 shares of the company's stock. Jiangsu Nhwa Pharmaceutical announced that the Chairman of the company, Sun Pengsheng, increased his holdings of the company's A-share stock by 237,900 shares through the Shenzhen Stock Exchange stock trading system on June 16, using his own funds and through centralized bidding trading. This increase in holdings by the company's Chairman Sun Pengsheng does not trigger a tender offer, change the shareholding distribution of the company, or alter the company's control rights, and will not have a significant impact on the company's governance structure and continued operations. 2. Qingdao Yunlu Advanced Materials Technology: Directors and senior management intend to collectively increase holdings by 4 million to 12 million yuan. Qingdao Yunlu Advanced Materials Technology announced that the company's directors and Vice Presidents Pang Jing, Zeng Yuanhua, Li Qinghua, and Stone, who serves as Vice President, CFO, and Company Secretary, intend to increase their holdings of the company's shares using their own funds or self-raised funds through the Shanghai Stock Exchange trading system within six months beginning on June 18, 2025. The intended amount for each increasing party is not less than 1 million yuan and not more than 3 million yuan, with a total intended increase amount for all parties of not less than 4 million yuan and not more than 12 million yuan. 3. Zhangjiagang Guangda Special Material: Chairman proposes a share buyback of 200 million to 400 million yuan. Zhangjiagang Guangda Special Material announced that the actual controller, Chairman, and General Manager Xu Weiming proposed that the company use a special loan provided by the Industrial and Commercial Bank of China, Zhangjiagang Branch, and its own funds to repurchase part of the company's shares through centralized bidding, for future employee shareholding plans and/or equity incentives, or for converting convertible corporate bonds issued by the listed company. The total amount of repurchase funds will not be less than 200 million yuan and not more than 400 million yuan. Large Transactions 1. Jiangsu Zhongchao Holding: Several subsidiaries are expected to collectively win projects worth 1.061 billion yuan. Jiangsu Zhongchao Holding announced that its wholly-owned subsidiaries Mingzhu Electric Cable, Yuanfang Electric Cable, Changfeng Electric Cable, and holding subsidiary Zhongchao Electric Cable have recently won multiple power cable projects, with a total bid amount of 1.061 billion yuan. This bid amount accounts for 19.29% of the company's audited total operating income for 2024. This article is reprinted from "Tencent Self-selected Stocks"; GMTEight Editor: Chen Xiaoyi.